Marc Koska, 2009

“We’re not saving lives by being competitive.”

Koska investigated how syringe reuse could transmit infection and developed a mechanism intended to prevent a device from being used again. He also argued for sharing life-saving design ideas widely. The primary record for Marc Koska identifies Koska’s 2009 TED talk and later TED interview on single-use syringes and preventing unsafe reuse. Reading Koska’s source beside Koska’s words separates Koska’s verified context from Koska’s later paraphrase. November 5 orders Koska’s series; November 5 does not tie Koska’s statement to Koska’s historical anniversary for Koska. The paired references let Koska’s readers compare Koska’s wording with Koska’s institutional record and Koska’s biography. That documented trail for Koska preserves Koska’s audience, Koska’s purpose, and Koska’s necessary limitation. Editors can quote Koska while keeping Koska’s original question visible to Koska’s readers.

The sentence distinguishes public-health impact from commercial advantage. When a safety feature becomes common, standards, procurement, training, and supply chains can protect far more patients than one product alone. A safer syringe does not fix every injection risk. Manufacturing quality, availability, disposal, staff training, needlestick prevention, and unnecessary injections remain part of the system. For Koska, the line becomes Koska’s interpretive lens rather than Koska’s complete clinical guidance. Applying Koska’s idea requires Koska’s current evidence, Koska’s affected communities, and Koska’s suitable outcomes. In health reporting, Koska should guide Koska’s inquiry before Koska supports Koska’s conclusion. A careful reading of Koska separates Koska’s descriptive findings from Koska’s moral judgment and Koska’s policy choice. Each layer around Koska needs Koska-specific support plus Koska-specific accountability. That structure keeps Koska’s memorable words connected to Koska’s documented scope and limits.

Koska applies these Koska-specific points now for Koska: Health programs can purchase quality-assured devices, monitor reuse and waste, and train workers in safe injection practice. Designers can share standards while keeping production reliable and affordable. Koska tied invention to diffusion. The line remains relevant whenever intellectual property, procurement, and competition determine how quickly a proven safety measure reaches people. The continuing question from Koska is practical for Koska: which decision embodies Koska’s principle? Readers can test Koska’s relevance when Koska’s practical questions for Koska ask who gains, where Koska’s risk falls, and how Koska’s improvement gets measured. Organizations honor Koska by assigning Koska-specific responsibility, Koska-specific resources, Koska-specific timelines, and Koska-specific public feedback. Individuals may use Koska for Koska-specific reflection while qualified care addresses Koska’s personal relevance. That distinction lets Koska inspire Koska-specific action without turning Koska’s editorial context into Koska’s medical advice. A transparent Koska review lets Koska’s principle face Koska’s real outcomes and necessary correction.